Table 1.
Variable | COVID-19 patients | Controls | p value |
---|---|---|---|
n = 16 | n = 32 | ||
Age (years) | 58.7 (24) | 65.7 (19) | 0.286 |
Male gender | 7 (43.7) | 16 (50.0) | 0.683 |
Medical history | |||
Asthma | 1 (6.3) | 1 (3.1) | 0.610 |
Smoker | 5 (31.3) | 15 (46.9) | 0.301 |
COPD | 1 (6.3) | 5 (15.6) | 0.355 |
Chronic kidney disease | 1 (6.3) | 11 (34.4) | 0.034 |
Chronic dialysis | 1 (6.3) | 2 (6.3) | 0.746 |
Obstructive sleep apnea | 0 (0) | 1 (3.1) | 0.475 |
Stroke | 2 (13.3) | NA | – |
Heart failure | 2 (12.5) | 4 (12.5) | 0.688 |
Diabetes mellitus | 6 (37.5) | 13 (40.6) | 0.835 |
Essential hypertension | 7 (43.8) | 21 (65.6) | 0.147 |
Ocular historya | |||
Glaucoma | 1 (6.3) | 4 (12.5) | 0.504 |
Dry-eye disease | 0 (0) | 2 (6.2) | 0.307 |
Status post cataract surgery | 1 (6.3) | 10 (31) | 0.052 |
Status post vitrectomy | 1 (6.3) | 1 (3.1) | 0.610 |
Baseline patient characteristics of consecutive patients with confirmed COVID-19 and patients not suspected of having COVID-19 admitted to Shamir medical center during March and April 2020. Values are presented as mean (standard deviation) for continuous variable and as number (percent) for categorical variables. COVID-19, Coronavirus disease 2019. COPD, chronic obstructive pulmonary disease
aIn one or both eyes